ANNOVIS

Welcome to the Brand page for “ANNOVIS”, which is offered here for The mark consists of the term annovis with a crescent design above and below the term.;pharmaceutical preparations for the treatment of cognitive disorders, neurological disorders, neurodegenerative disorders, dementia, parkinson's disease, alzheimer's disease and other neurodegenerative diseases; pharmaceutical preparations in the nature of a neuroprotective agent;color is not claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “ANNOVIS” is believed to be currently owned by “Annovis BIO, Inc.”